Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that the United States Patent Office has granted U.S.
April 4, 2011 (Washington, DC) — Results from a study of 927 patients with osteoarthritis of the knee have shown that a topical solution of the nonsteroidal anti-inflammatory agent diclofenac was ...
The authors survey the approved applications of dimethyl sulfoxide USP, PhEur across the healthcare industry and consider the suitability of DMSO from a regulatory and formulation compatibility ...
Q: What is your opinion of the pain reliever DMSO? I know it’s used on horses to relieve tendinitis and arthritis. I’ve heard that it helps with sprains and arthritis in people, but I’m not sure how ...
The authors review the regulatory changes associated with the use of dimethyl sulfoxide in finished pharmaceutical dosage forms. Dimethyl sulfoxide (DMSO) has long been appreciated as a versatile ...
Background: Treatment of osteoarthritis with oral NSAID therapy provides pain relief but carries a substantial risk of adverse effects. Topical NSAID therapy offers an alternative to oral treatment, ...
Dear Dr. Roach: What is your take on the benefits versus risks of DMSO? -- W.R. Answer: DMSO (dimethyl sulfoxide) has only one use approved by the Food and Drug Administration, in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback